Fusidic Acid CAS 6990-06-3

Fusidic Acid is a kind of antibiotic product for curing infections caused by sensitive bacteria especially staphylococci, such as carious osteitis, blood poisoning, encarditis, repeated infected cystic fibrosis, pneumonia, cutaneo-infection & soft tissue infection, surgery infection & wound infection.

Item		Standard Regulation	Test Result
Appearance	Appearance	White or almost white, crystalline powder	white crystalline powder
Impurity	M	≤1.0%	1.0%
	G	≤0.7%	Not detected
	L	≤0.5%	Not detected
	B	≤0.4%	Not detected
	A	≤0.3%	Not detected
	H	≤0.10%	Not detected
	C	≤0.2%	Not detected
	D	≤0.2%	Not detected
	F	≤0.2%	Not detected
	I	≤0.2%	Not detected
	K	≤0.2%	Not detected
	N	≤0.2%	Not detected
	Main unspecified impurities	≤0.10%	Not detected
	Total impurities	≤2.0%	0.1%

Fusidic Acid CAS 6990-06-3

Product: Fusidic Acid 6990-06-3
Chemical Name: Fusidic acid; Fusidic Acid API; Fusidic Acid Active Pharmaceutical Ingredient; CAS 6990-06-3; Acide Fusidique; Acido Fusidico; 6990-06-3;
CAS No.: 6990-06-3
Physical characteristics: white powder
Molecular Formula: C₃₁H₄₈O₆·1/2 H₂O
Molecular Weight: 525.7
MDL Number: MFCD00865135
NSC Number: 56192

Fusidic Acid CAS 6990-06-3 was extracted in 1962 for the first time by the Danish LEO Pharma from the fermentation broth of Fusidium coccineum. It is a narrow-spectrum, high-efficiency and anti gram-positive bacteria antibiotic widely used in foreign countries. Fusidic Acid, as a typical high efficiency antibiotic, although has been widely used in foreign countries for more than 30 years (few used in domestic clinical), still keeps relatively strong antibacterial activity and very low resistance to most staphylococcus strain, more and more receives people's attention, and becomes new selection of anti resistant staphylococcus aureus (MRSA).

Fusidic acid, with CAS number 6990-06-3, is an antibiotic medication that offers several benefits in the treatment of bacterial infections. Here are some of the benefits of Fusidic Acid:

1. Active against Gram-Positive Bacteria: Fusidic acid is primarily effective against Gram-positive bacteria, including strains of Staphylococcus aureus (including methicillin-resistant Staphylococcus aureus or MRSA) and Streptococcus species. It works by inhibiting bacterial protein synthesis, thereby preventing the growth and replication of susceptible bacteria.

2. Treatment of Skin Infections: Fusidic acid is commonly used topically for the treatment of skin infections, such as impetigo, infected wounds, and infected dermatitis. It helps eliminate or control bacterial growth at the site of infection, reducing inflammation and promoting wound healing.

3. Ophthalmic Infections: Fusidic acid can be used in ophthalmic preparations for the treatment of bacterial eye infections, such as conjunctivitis and blepharitis. It helps eradicate bacterial pathogens in the eye, relieving symptoms and promoting recovery.

4. Limited Development of Antibiotic Resistance: Fusidic acid has shown a relatively low rate of resistance development compared to other antibiotics. It is considered an important option for the treatment of infections caused by methicillin-resistant Staphylococcus aureus (MRSA) strains that are susceptible to fusidic acid.

5. Combination Therapy: Fusidic acid can be used in combination with other antibiotics for the treatment of certain infections, such as bone and joint infections or respiratory tract infections caused by susceptible bacteria. Combining fusidic acid with other antibiotics can enhance the overall antibacterial activity and broaden the spectrum of coverage.

6. Well-Tolerated: Fusidic acid is generally well-tolerated when used topically or in ophthalmic formulations. Side effects are usually mild and include skin irritation, itching, or burning sensations at the application site. Systemic side effects are rare when used topically.

It is important to note that the use of Fusidic acid should be based on the guidance of a healthcare professional. The specific benefits and appropriate usage of the medication may vary depending on the type of infection, the susceptibility of the bacteria, and individual patient factors.

1. Payment term

TT, LC

2. Delivery date

Negotiable

3. Market

Middle East / Africa / Asia / South America / Europe

4. Sample

Available
5. Executive standards
CP, EP, IP

6. Qualification certificate
Registration "A" status of raw material packaging, Notification of Approval of marketing application for chemical API, WC, COPP, CEP, EUGMP, US DMF registration number, India Registration certificate, Brazil registration, Malaysia registration, etc.

7. Packaging size specification

Inner package: single-layer polyethylene bag and aluminum foil bag.

Outer package: fiber drum.

Packaging size: 25 kg/drum; 1kg/drum; 5kg/drum.

We have branch offices in Dubai and India

we have own reliable & Long-term cooperative & experienced factory

Variety products for selection from China and India

We can customize according to your requirements

We can do OEM & ODM

We can offer N-1 to API

Hot Tags: fusidic acid cas 6990-06-3, China fusidic acid cas 6990-06-3 manufacturers, suppliers, factory, antibiotics api for collaborating on quality improvement with suppliers, antibiotics api for offering quality advice to suppliers, antibiotics api for partnering on market expansion with suppliers, antibiotics api for jointly developing new products with suppliers, antibiotics api for working together on cost reduction with suppliers, antibiotics api for sharing best practices with suppliers